Upgrade to SI Premium - Free Trial

Catyalyst Pharmaceutical Partners (CPRX) Cuts Q2 Loss by 1c

August 16, 2011 8:05 AM
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) reported Q2 EPS of ($0.06), versus ($0.07) reported last year.

Categories

Earnings